西藥試題庫及答案

西藥（共1000題

1000分）一、A1/A2型題、A1/A2型題：每一道考試題下面有A、B、C、D、E五個(gè)備選答案。請從中選擇一個(gè)最佳答案。(990分)MACROBUTTONDoFieldClick[修改]MACROBUTTONDoFieldClick[刪除]（）1、脂溶性藥物從胃腸道吸收，主要是通過MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.主動(dòng)轉(zhuǎn)運(yùn)吸收B.簡單擴(kuò)散吸收C.易化擴(kuò)散吸收D.通過離子通道吸收E.胞飲方式吸收（）2、葡萄糖酸鈣對該藥物的腸道吸收影響最大的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.異煙肼B.氯霉素C.氨芐西林D.四環(huán)素E.阿莫西林（）3、牛源性藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.胞磷膽堿B.人胰島素C.甲睪酮D.琥珀酰明膠注射液（佳樂施，血定安）E.生長激素（）4、鈣拮抗藥的基本作用是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.阻止鈣離子的重吸收B.降低鈣離子的血漿蛋白結(jié)合率C.阻止鈣離子從細(xì)胞內(nèi)外流D.阻止鈣離子從體液向細(xì)胞內(nèi)轉(zhuǎn)移E.與鈣離子絡(luò)合使之失去作用（）5、有關(guān)沙利度胺描述錯(cuò)誤的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.有致畸作用B.蛋白結(jié)合率低C.在機(jī)體各組織分布廣泛D.水溶性低，在水中不穩(wěn)定E.口服生物利用度低（）6、屬于靶向抗腫瘤藥的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.吉西他濱B.埃羅替尼C.伊立替康D.多西他賽E.紫杉醇（）7、下列描述加替沙星的特點(diǎn)正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.有嚴(yán)重的光敏副反應(yīng)B.兒童可以應(yīng)用C.易導(dǎo)致腎臟毒性D.與其他喹諾酮類抗生素?zé)o交叉耐藥性E.抗菌活性低于氧氟沙星（）8、對雌激素受體起選擇性抑制的藥物為MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.伊馬替尼B.長春堿C.他莫昔芬D.門冬酰胺酶E.多柔比星（）9、可作為抑制胃酸分泌過多的首選藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.解熱鎮(zhèn)痛藥B.非甾體抗炎藥C.質(zhì)子泵抑制藥D.胃腸動(dòng)力藥E.硫脲類（）10、下列有關(guān)煙酸的描述錯(cuò)誤的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.屬于B族維生素B.在體內(nèi)迅速轉(zhuǎn)化成煙酰胺C.口服15～20min達(dá)峰濃度D.半衰期約為90minE.具有線性動(dòng)力學(xué)特性（）11、符合線性藥物動(dòng)力學(xué)特征的藥物，其生物半衰期的1個(gè)重要特點(diǎn)是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.取決于開始濃度B.主要取決于首次劑量C.取決于給藥途徑D.與開始濃度、首次劑量、給藥途徑均無關(guān)E.與開始濃度、首次劑量、給藥途徑均有關(guān)（）12、由于大量輸入生理鹽水可引起的反應(yīng)是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.低鈉和堿中毒B.低鈉和酸中毒C.氯離子負(fù)荷增高和酸中毒D.乳酸負(fù)荷增加E.高氯和低鈉（）13、普魯本辛（溴丙胺太林）禁用于MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.肝損害者B.心衰竭患者C.青光眼患者D.潰瘍病患者E.腸痙攣患者（）14、癌癥患者使用止痛藥原則正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.癌癥患者使用止痛藥可不受任何限制B.癌痛藥可以突然停藥C.哌替啶可用于慢性癌痛的長期止痛D.阿片類藥物用于癌痛治療不受常用劑量限制E.非甾體抗炎藥與阿片類藥物可輪流替代應(yīng)用（）15、托品類生物堿中樞作用相對較輕的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.阿托品B.山莨菪堿C.莨菪堿D.樟柳堿E.東莨菪堿（）16、需要載體的轉(zhuǎn)運(yùn)方式是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.濾過B.主動(dòng)轉(zhuǎn)運(yùn)C.簡單擴(kuò)散D.膜孔轉(zhuǎn)運(yùn)E.胞吐（）17、屬于第三代口服頭孢菌素MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.頭孢氨芐B.頭孢呋辛酯C.頭孢妥侖匹酯D.頭孢克洛E.頭孢孟多（）18、咽部念珠菌病可選用MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.鏈霉素B.兩性霉素BC.阿莫西林D.紅霉素E.克霉唑（）19、屬于紫杉醇劑量限制性毒性MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.皮膚不良反應(yīng)B.胃腸道反應(yīng)C.心臟損害D.血管系統(tǒng)不良反應(yīng)E.骨髓抑制（）20、有關(guān)血漿半衰期的描述正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.與血藥濃度的高低正相關(guān)B.隨血藥濃度的下降而延長C.在一定劑量范圍內(nèi)固定不變，與血藥濃度高低無關(guān)D.在任何劑量下，固定不變E.與首次服用的劑量成正相關(guān)（）21、那格列奈治療2型糖尿病的機(jī)制是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.直接分解葡萄糖B.促進(jìn)胰島素分泌C.增加機(jī)體臟器和組織對胰島素的敏感性D.加強(qiáng)外周組織對葡萄糖的攝取E.抑制小腸葡萄糖的吸收（）22、特拉唑嗪的降壓作用機(jī)制是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.選擇性激動(dòng)β受體B.阻斷α受體C.激動(dòng)α受體D.選擇性阻斷α受體E.直接擴(kuò)張血管（）23、腎功能不良但肝功能尚正常的患者可以應(yīng)用的抗感染藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.慶大霉素B.妥布霉素C.鏈霉素D.頭孢哌酮E.西索米星（）24、用于治療慢性粒細(xì)胞白血病的藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.氟尿嘧啶B.伊馬替尼C.沙利度胺D.絲裂霉素E.他莫昔芬（）25、不屬于溶血栓藥的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.纖溶酶原激活物tPAB.尿激酶C.蛇毒抗凝酶D.肝素E.鏈激酶（）26、影響氟喹諾酮類抗生素起效時(shí)間的藥動(dòng)學(xué)參數(shù)是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.藥時(shí)曲線下面積B.血漿半衰期C.腎清除率D.表觀分布容積E.達(dá)峰時(shí)間（）27、下列藥物可首選緩解中度癌痛的藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.二氫埃托啡片B.鹽酸曲馬朵緩釋片C.酒石酸二氫可待因控釋片D.硫酸嗎啡控釋片E.芬太尼透皮貼劑（）28、下列藥物可首選緩解重度癌痛的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.吲哚美辛（消炎痛）控釋片B.鹽酸曲馬朵緩釋片C.芬太尼透皮貼劑D.硫酸嗎啡控釋片E.鹽酸哌替啶注射液（）29、目前不再使用的治療三叉神經(jīng)痛的藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.苯妥英鈉B.卡馬西平C.γ-氨基丁酸D.氯苯甘醚E.酒精（）30、慶大霉素不適宜治療的感染是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.變形桿菌感染B.銅綠假單胞菌感染C.鏈球菌感染D.淋球菌感染E.幽門螺桿菌感染（）31、通過活性代謝物發(fā)揮降血壓作用的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.氯沙坦B.伊普沙坦C.伊貝沙坦D.替米沙坦E.纈沙坦（）32、可參與抗結(jié)核治療聯(lián)合用藥的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.舒他西林B.舒巴坦C.克拉維酸D.甲氧芐啶E.氧氟沙星（）33、ACEI除降血壓外還可用于MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.凝血功能異常B.心絞痛C.糖尿病D.銀屑病E.充血性心衰（）34、屬于H受體阻斷藥的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.昂丹司瓊B.西替利嗪C.法尼替丁D.西咪替丁E.奧美拉唑（）35、與頭孢呋辛屬于同一代抗生素的藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.頭孢噻吩B.頭孢哌酮C.頭孢孟多D.頭孢氨芐E.頭孢曲松（）36、屬新一代的喹諾酮類藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.氧氟沙星B.左氟沙星C.加替沙星D.培氟沙星E.依諾沙星（）37、阿米巴肝膿腫的首選藥物為MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.喹寧B.甲硝唑C.土霉素D.依米丁E.乙酰胂胺（滴維凈）（）38、氟喹諾酮類藥物中安全性相對最好的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.依諾沙星B.莫西沙星C.左氧氟沙星D.司帕沙星E.環(huán)丙沙星（）39、屬于阿片受體激動(dòng)藥的鎮(zhèn)痛藥是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.依托度酸B.氨基葡萄糖C.羥考酮D.舒林酸E.氯諾昔康（）40、伊立替康抗腫瘤作用主要通過抑制MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.堿性磷酸酶B.二氫葉酸還原酶C.HMG-CoA還原酶D.拓?fù)洚悩?gòu)酶E.腺苷脫氧酶（）41、較易引起兒童血尿的藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.頭孢氨芐B.頭孢他啶C.頭孢哌酮D.頭孢曲松E.頭孢拉定（）42、下列藥物建議孕婦懷孕早期補(bǔ)充用以預(yù)防胎兒神經(jīng)管畸形發(fā)生的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.鐵劑B.葉酸C.C族維生素D.A族維生素E.鈣劑（）43、下列屬于西布曲明治療肥胖癥的機(jī)制是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.抑制5-羥色胺及去甲腎上腺素的再攝取B.引起單胺神經(jīng)遞質(zhì)釋放C.抑制單胺氧化酶的活性D.抑制脂肪從胃腸道吸收E.激動(dòng)β腎上腺素受體提高能量代謝及產(chǎn)熱反應(yīng)（）44、下列描述苯唑西林性質(zhì)和作用的說法最確切的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.本品有耐酶性能，適用于產(chǎn)生青霉素酶的細(xì)菌所引起的感染B.細(xì)菌對青霉素耐藥后可選用本品C.本品對細(xì)菌產(chǎn)生的青霉素酶有抑制作用D.本品適用于一切耐青霉素的葡萄球菌所致的各種感染E.本品適用于葡萄球菌產(chǎn)酶株所致的周圍感染（）45、屬于抗躁狂藥的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.地西泮B.丙米嗪C.氯扎美酮D.丁螺環(huán)酮E.碳酸鋰（）46、有關(guān)羅哌卡因敘述正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.本品為酯類局麻藥B.本品為酰胺類局麻藥C.對普魯卡因過敏者禁用本品D.本品的特點(diǎn)是作用時(shí)間短E.本品主要經(jīng)細(xì)胞色素P酶代謝（）47、可用于血漿代用品的溶液是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.生理鹽水B.葡萄糖注射液C.乳酸鈉林格液D.羥乙基淀粉E.高滲鹽水（）48、大多數(shù)藥物吸收的機(jī)制是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.主動(dòng)轉(zhuǎn)運(yùn)吸收B.水溶擴(kuò)散吸收C.易化擴(kuò)散吸收D.簡單擴(kuò)散吸收E.膜動(dòng)轉(zhuǎn)運(yùn)吸收（）49、臨床應(yīng)用時(shí)常用來緩解順鉑腎毒性的方法是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.加用昂丹司瓊B.水化和利尿C.調(diào)節(jié)酸堿度D.延長給藥時(shí)間E.增加給藥頻率（）50、癌癥術(shù)前化療的意義正確的說法是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.直接殺傷腫瘤細(xì)胞或誘導(dǎo)腫瘤細(xì)胞凋亡B.降低腫瘤復(fù)發(fā)率C.進(jìn)行新抗腫瘤藥的臨床研究D.防止腫瘤擴(kuò)散E.提高患者對手術(shù)的耐受力（）51、通過活性代謝物發(fā)揮降壓作用的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.依那普利B.賴諾普利C.卡托普利D.吲達(dá)帕胺E.氫氯噻嗪（）52、與青霉素V抗菌譜最近似的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.阿莫西林B.阿帕西林C.美洛西林D.苯唑西林E.青霉素G（）53、使用栓劑時(shí)方法不正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.不去掉外面鋁箔或包裝B.塞栓時(shí)注意戴衛(wèi)生指套C.左側(cè)臥位并彎曲右膝D.將栓劑尖端朝前插入E.盡量在給藥后1小時(shí)內(nèi)不排大便（）54、根據(jù)對費(fèi)用和結(jié)果以錢數(shù)（貨幣）進(jìn)行的測量和評估，計(jì)算和比較錢數(shù)得失凈值或費(fèi)用與效益比值的經(jīng)濟(jì)學(xué)分析方法是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.最小成本分析法B.成本效果分析法C.成本費(fèi)用分析法D.成本效益分析法E.最小二乘法（）55、不具有雙硫侖樣反應(yīng)的藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.地西泮B.呋喃唑酮C.奧硝唑D.伏立康唑E.酮康唑（）56、可進(jìn)行新藥，臨床試驗(yàn)基地的單位必須具備的條件是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.具有藥物臨床試驗(yàn)資格的機(jī)構(gòu)B.三級甲等醫(yī)院C.可以自行選定醫(yī)院D.省級以上的醫(yī)院E.綜合性醫(yī)院（）57、合用后可使左旋多巴作用加強(qiáng)而不良反應(yīng)減少的藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.卡比多巴B.維生素CC.利血平D.異煙肼E.丙胺太林（）58、目前我國化學(xué)藥新藥在新藥審評中分成MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.3類B.5類C.10類D.6類E.8類（）59、賁昔洛韋屬于核苷類抗皰疹病毒藥，其前體藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.齊多夫定B.泛昔洛韋C.更昔洛韋D.金剛烷胺E.干擾素（）60、需整片吞服的制劑是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.薄膜衣片B.滲透泵型控釋片C.所有異形片D.糖包衣片E.小劑量片劑（）61、氨基糖苷類藥物不宜靜脈注射的主要原因是為了防止MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.過敏性休克B.神經(jīng)肌肉阻滯反應(yīng)C.出血D.發(fā)生口麻和呃逆反應(yīng)E.四肢麻痹（）62、復(fù)方對乙酰氨基酚片的正常情況下的外觀性狀為MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.淡綠色片，味微酸B.深紅色片C.橙黃色片，味微苦D.白色片，味微酸E.綠色，味甘（）63、屬于"瘦肉精"主要成分的藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.媽富?。ㄈパ踉邢〣.克侖特羅C.多西環(huán)素D.潑尼松E.地塞米松（）64、新藥Ⅰ期臨床耐受性試驗(yàn)的受試者應(yīng)該是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.女性志愿者B.男性志愿者C.男、女比例隨機(jī)的健康志愿者D.所有愿意參加的健康志愿者E.患有新藥適應(yīng)證疾病的患者志愿者（）65、患者使用氣霧劑時(shí)，正確的操作方法是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.深吸氣的同時(shí)撳下按鈕→屏氣→漱口B.深呼氣→吸撳同步吸氣→屏氣→漱口C.深呼氣→吸撳同步→深而長吸氣→漱口D.深呼氣→撳下按鈕→深而長吸氣→漱口E.撳下按鈕→深而長吸氣→屏氣→漱口（）66、需要對茶堿類藥物進(jìn)行血藥濃度監(jiān)測主要是因?yàn)镸ACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.生物利用度低B.給常規(guī)劑量，但血藥濃度差異較大，治療窗窄C.不同個(gè)體半衰期不定D.有效血藥濃度范圍大E.動(dòng)力學(xué)呈線性特征（）67、關(guān)于新藥臨床試驗(yàn)的敘述錯(cuò)誤的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.試驗(yàn)因?yàn)闃颖緮?shù)有限而存在一定的局限性B.做過臨床試驗(yàn)后可不做上市后評價(jià)C.除特殊情況外，一般不在老年人、兒童及孕婦等人群中進(jìn)行D.受試者一般不應(yīng)該是患有其他疾病或正在使用其他藥物的患者E.不能發(fā)生超量用藥情況（）68、根據(jù)我國《藥品管理法實(shí)施條例》的界定，新藥是指MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.首次在我國生產(chǎn)的B.未曾在中國境內(nèi)上市銷售的C.我國人員有參與研制的D.未曾在中國境內(nèi)生產(chǎn)的E.未在世界上出現(xiàn)的（）69、飯后服用吸收更完全的頭孢菌素類藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.頭孢西丁B.頭孢泊肟酯C.頭孢羥氨芐D.頭孢他啶E.頭孢克洛（）70、應(yīng)用后可能引起明顯干咳的藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.鈉離子通道阻滯藥B.ACE抑制藥C.5-HT受體阻斷藥D.α受體阻斷藥E.鈣拮抗藥（）71、應(yīng)用羥乙基淀粉可能造成損害的器官是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.心B.腎C.膀胱D.胃E.小腸（）72、可以讓臨床試驗(yàn)受試者的權(quán)益得到很好保障的主要措施是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.藥物非臨床研究管理規(guī)范B.倫理委員會(huì)和知情同意書C.藥物經(jīng)營質(zhì)量管理規(guī)范D.標(biāo)準(zhǔn)參比制劑和試驗(yàn)制劑配對E.國家衛(wèi)生行政管理部門的參與（）73、有關(guān)依從性的敘述錯(cuò)誤的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.依從性是指患者對醫(yī)師醫(yī)囑的執(zhí)行情況B.指患者按其家屬指示的方法用藥C.在我國患者服藥依從性差的現(xiàn)象十分常見D.新藥開發(fā)的目的之一可以是改善患者的依從性E.考慮患者依從性因素，才能客觀評價(jià)試驗(yàn)結(jié)果（）74、不屬于藥物經(jīng)濟(jì)學(xué)評價(jià)方法的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.成本效用分析B.成本利潤分析C.成本效益分析D.最小成本分析E.成本效果分析（）75、最能反映移植受者服用環(huán)孢素后的實(shí)際吸收情況的藥動(dòng)學(xué)參數(shù)是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.CB.CC.AUCD.tE.CL（）76、可用于治療抗生素治療中發(fā)生的難辨梭狀芽孢桿菌腸炎繼發(fā)感染的藥物為MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.紅霉素B.鏈霉素C.去甲萬古霉素D.頭孢哌酮E.青霉素（）77、降糖藥聯(lián)合應(yīng)用不合理的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.苯乙雙胍+磺酰脲類B.阿卡波糖+磺酰脲類C.兩種磺酰脲類聯(lián)用D.長效胰島素+短效胰島素E.中成藥+磺酰脲類（）78、兒童補(bǔ)液鹽的處方進(jìn)行了改進(jìn)，新的處方中主要改進(jìn)的方面是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.增加了氯化鉀的量B.增加了無水葡萄糖的量C.降低了總滲透壓，使在245mOsm/LD.增加了補(bǔ)液的滲透壓E.維持了原氯化鉀的量（）79、臨床試驗(yàn)進(jìn)行藥品系統(tǒng)性研究的受試對象是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.只有病人B.只有健康志愿者C.病人或健康志愿者D.生產(chǎn)人員E.研究人員（）80、對于肺部給藥特點(diǎn)的敘述不正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.吸收面積非常大B.由于肺血容量豐富，蛋白和多肽類肺部給藥吸收快C.存在肝首過效應(yīng)D.可提高藥物的生物利用度E.由于肺泡表皮薄，藥物較易透過吸收（）81、屬于合理的聯(lián)合用藥是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.紅霉素與琥乙紅霉素B.美托洛爾與特布他林C.左旋多巴與芐絲肼D.交沙霉素與培菲康E.慶大霉素與鏈霉素（）82、感冒藥康泰克被淘汰的原因是其有效成分中含有MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.對乙酰氨基酚B.去氧腎上腺素C.苯丙醇胺D.氯苯那敏E.偽麻黃堿（）83、屬于不合理配伍的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.哌替啶+阿托品B.慶大霉素+紅霉素C.紅霉素+林可霉素D.磺胺嘧啶+甲氧芐啶E.左旋多巴+芐絲肼（）84、英文縮寫"SARS"的中文全稱是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.系統(tǒng)性紅斑狼瘡綜合征B.急性呼吸窘迫綜合征C.嚴(yán)重急性呼吸綜合征D.消化性潰瘍E.慢性支氣管炎（）85、我國規(guī)定新藥是指MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.國外已上市銷售的藥品B.由我國研制生產(chǎn)的藥品C.新藥是我國未生產(chǎn)過和從未進(jìn)口過的藥品D.國外已生產(chǎn)藥品的仿制品E.新藥是我國進(jìn)口的藥品（）86、關(guān)于藥物不良反應(yīng)定義的說法正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.有意的超劑量、錯(cuò)誤用藥造成的有害反應(yīng)B.無意的超劑量、錯(cuò)誤用藥造成的有害反應(yīng)C.正常用法、用量下出現(xiàn)的與治療目的無關(guān)的有害反應(yīng)D.有效成分改變的藥品引起的有害反應(yīng)E.出產(chǎn)檢驗(yàn)不合格藥品引起的有害反應(yīng)（）87、復(fù)方制劑氨芐西林丙磺舒分散片中，加入丙磺舒是為了MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.促進(jìn)氨芐西林的吸收B.延緩氨芐西林的代謝C.延緩氨芐西林的排泄D.擴(kuò)大氨芐西林的抗菌譜E.減少氨芐西林的耐藥性（）88、解救有機(jī)磷中毒時(shí)，盡早應(yīng)用阿托品是為了MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.直接起解毒作用B.防止中毒過深而無法解救C.癥狀對抗D.使解磷定的作用更強(qiáng)E.保護(hù)機(jī)體的重要器官組織（）89、屬于外科抗生素預(yù)防用藥原則的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.任何情況下清潔手術(shù)都不得使用抗菌藥物預(yù)防感染B.清潔一污染手術(shù)的預(yù)防用藥時(shí)間術(shù)后6hC.清潔手術(shù)預(yù)防用藥時(shí)間不超過24hD.首選廣譜抗生素E.預(yù)防用藥的時(shí)間需要維持到傷口愈合（）90、《中國藥典》（2010年版）規(guī)定"陰涼處"是指MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.2～10℃B.2℃以下C.15℃以下D.不超過20℃E.室溫避光（）91、配制好的腸外營養(yǎng)液(PN)使用完的時(shí)間不應(yīng)超過MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.3hB.6hC.12hD.24hE.48h（）92、《中國藥典》（2010年版）中醋酸的濃度為MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.80%～90%(g/g)B.99%〔g/g〕C.40%(g/g)D.36%～37%（g/g）E.30%(g/g)（）93、在新藥臨床試驗(yàn)中，考察新藥上市后療效和不良反應(yīng)（尤其是罕見不良反應(yīng)）的階段是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.Ⅰ期和Ⅱ臨床試驗(yàn)B.Ⅱ期和Ⅲ期臨床試驗(yàn)C.Ⅲ期臨床試驗(yàn)D.Ⅳ期臨床試驗(yàn)E.生物等效性評價(jià)（）94、能有效治療腎絞痛的藥物是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.山莨菪堿和新斯的明合用B.阿托品和毒扁豆堿合用C.哌替啶和嗎啡合用D.阿托品和哌替啶合用E.哌替啶和新斯的明合用（）95、關(guān)于普魯卡因作用表述正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.為全身麻醉藥B.可用于表面麻醉C.穿透力較強(qiáng)D.主要用于浸潤麻醉E.不用于傳導(dǎo)麻醉（）96、關(guān)于鹽酸普魯卡因的性質(zhì)正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.結(jié)構(gòu)中有芳伯氨基，易氧化變色B.不易水解C.本品最穩(wěn)定的pH是7.0D.對紫外線和重金屬穩(wěn)定E.為達(dá)到最好滅菌效果，可延長滅菌時(shí)間（）97、關(guān)于鹽酸利多卡因性質(zhì)表述正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.本品對酸不穩(wěn)定B.本品對堿不穩(wěn)定C.本品易水解D.本品對熱不穩(wěn)定E.本品比鹽酸普魯卡因穩(wěn)定（）98、關(guān)于巴比妥類藥物理化性質(zhì)表述正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.巴比妥類藥物易溶于水B.巴比妥類藥物加熱易分解C.含硫巴比妥類藥物有不適臭味D.巴比妥藥物在空氣中不穩(wěn)定E.通常對酸和氧化劑不穩(wěn)定（）99、對巴比妥類藥物構(gòu)效關(guān)系表述正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.R的總碳數(shù)1～2最好B.R(R)應(yīng)為2～5碳鏈取代，或有一為苯環(huán)取代C.R以乙基取代起效快D.若R(R)為H原子，仍有活性E.1-位的氧原子被硫取代起效慢（）100、對苯巴比妥鈉的表述正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.具有芳胺結(jié)構(gòu)B.其鈉鹽對水穩(wěn)定C.臨床上用于治療失眠、驚厥和癲癇大發(fā)作D.苯巴比妥鈉在60%丙三醇水溶液中有一定的穩(wěn)定性E.苯巴比妥鈉水解后仍有活性（）101、對硫噴妥鈉表述正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.本品系異戊巴比妥4-位氧原子被取代得到的藥物B.本品系異戊巴比妥2-位氧原子被取代得到的藥物C.藥物的脂溶性小，不能透過血腦屏障D.本品為長效巴比妥藥物E.本品不能用于抗驚厥（）102、對散劑特點(diǎn)敘述錯(cuò)誤的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.制備簡單、劑量易控制B.外用覆蓋面積大，但不具保護(hù)收斂功能C.貯存、運(yùn)輸、攜帶方便D.表面積大、易分散、起效快E.便于小兒服用（）103、下列不是粉碎目的的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.提高難溶性藥物的溶出度和生物利用度B.有利于提高固體藥物在液體中的分散度C.有助于提取藥材中的有效成分D.有利于混合E.有利于藥物穩(wěn)定（）104、對氯丙嗪的敘述錯(cuò)誤的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.對體溫調(diào)節(jié)的影響與周圍環(huán)境有關(guān)B.抑制體溫調(diào)節(jié)中樞C.只使發(fā)熱者體溫降低D.在高溫環(huán)境中使體溫升高E.在低溫環(huán)境中使體溫降低（）105、氯丙嗪不能用于某種原因引起的嘔吐，原因是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.尿毒癥B.癌癥C.放射病D.強(qiáng)心苷E.暈動(dòng)?。ǎ?06、處方的結(jié)構(gòu)包括MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.前記、正文、后記B.處方編號、藥名、簽名C.患者的姓名、性別、年齡、病歷號等D.藥品的名稱、規(guī)格、數(shù)量、用法用量等E.醫(yī)療機(jī)構(gòu)名稱、醫(yī)師簽名、藥學(xué)技術(shù)人員簽名（）107、關(guān)于處方的敘述下列正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.處方只能由注冊的執(zhí)業(yè)醫(yī)師開具B.處方可以由注冊的執(zhí)業(yè)助理醫(yī)師開具C.處方可以由藥學(xué)專業(yè)技術(shù)人員開具D.處方可以由注冊的執(zhí)業(yè)醫(yī)師和執(zhí)業(yè)藥師開具E.處方可以由注冊的執(zhí)業(yè)醫(yī)師和藥學(xué)專業(yè)技術(shù)人員開具（）108、按照《處方管理辦法》，急診處方的顏色應(yīng)為MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.白色B.綠色C.淡綠色D.淡紅色E.淡黃色（）109、處方的前記不包括MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.醫(yī)療機(jī)構(gòu)名稱、處方編號B.患者的姓名、性別、年齡C.藥品的名稱、規(guī)格、數(shù)量D.臨床診斷E.科別、門診號（）110、關(guān)于處方調(diào)配的一般程序包括MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.認(rèn)真審核處方B.準(zhǔn)確調(diào)配藥品C.正確書寫藥袋或粘貼標(biāo)簽、包裝D.向患者交付處方藥品時(shí)，應(yīng)當(dāng)對患者進(jìn)行用藥說明與指導(dǎo)E.以上都包括（）111、調(diào)配藥品時(shí)MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.需要仔細(xì)閱讀處方，但不用照藥品順序逐一調(diào)配B.應(yīng)同時(shí)調(diào)配多張?zhí)幏?，以免患者等待時(shí)間過長C.調(diào)配好的處方不需要藥師簽名或蓋章D.需要在每種藥品外包裝上分別貼上用法、用量、貯存條件等的標(biāo)簽E.藥品配齊后，為節(jié)約時(shí)間，不需要核對可直接都發(fā)給患者（）112、下列哪種藥品宜單獨(dú)放置MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.氯化鉀注射液B.氯化鉀控釋片C.生理鹽水D.5%葡萄糖E.以上都不是（）113、藥物的物理配伍變化包括MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.渾濁B.沉淀C.分層D.結(jié)晶E.以上都是（）114、脂肪乳劑在與其他藥物配伍時(shí)需慎重，因其易產(chǎn)生MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.水解B.破裂C.結(jié)晶D.變色E.渾濁（）115、在配置腸外營養(yǎng)液時(shí)微量元素和電解質(zhì)應(yīng)加入MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.脂肪乳B.水溶性維生素C.脂溶性維生素D.葡萄糖溶液E.氨基酸溶液（）116、關(guān)于配置腸外營養(yǎng)液注意事項(xiàng)的敘述不正確的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.混合順序非常重要，在終混前氨基酸可被加到脂肪乳劑中或葡萄糖中，以保證氨基酸對乳劑的保護(hù)作用B.鈣劑和磷酸鹽應(yīng)分別加在不同的溶液中稀釋，以免發(fā)生磷酸鈣沉淀C.混合液中可以加入其他藥物D.現(xiàn)配現(xiàn)用，24小時(shí)輸完，最多不超過48小時(shí)E.電解質(zhì)不應(yīng)直接加入脂肪乳劑中（）117、在配置腸外營養(yǎng)液時(shí)，Mg濃度應(yīng)控制在MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.<1.7mmol/LB.>1.7mmol/LC.<3.4mmol/LD.>3.4mmol/LE.<5.1mmol/L（）118、藥物的安全性評價(jià)必須執(zhí)行MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.GCPB.GMPC.GLPD.GAPE.GOP（）119、個(gè)體化給藥是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.針對患者個(gè)體的給藥方案B.根據(jù)每位患者的具體情況量身訂制的給藥方案C.根據(jù)每位患者制定的給藥方案D.針對癥狀制定的給藥方案E.針對方方面面的情況制定的給藥方案（）120、提高患者依從性需加強(qiáng)對患者的用藥指導(dǎo)，以下不是用藥指導(dǎo)的主要內(nèi)容的是MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.治療目的B.用法用量C.不良反應(yīng)D.注意事項(xiàng)E.藥品價(jià)格（）121、由遺傳因素產(chǎn)生的不良反應(yīng)為MACROBUTTONDoFieldClick[上移]MACROBUTTONDoFieldClick[下移]MACROBUTTONDoFieldClick[展開]MACROBUTTONDoFieldClick[替換]MACROBUTTONDoFieldClick[刪除]A.B型藥物不良反應(yīng)B.A型藥物不良反應(yīng)C.D型藥物不良反應(yīng)D.E型藥物不良反應(yīng)E.C型藥物不良反應(yīng)（）122、阿托品用于治療胃腸道痙攣時(shí)，引起口干、心悸、尿潴留等反應(yīng)屬于MACROBUTTONDoFie